There are 2789 resources available
197P - Application of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer
Presenter: Laura Sánchez Escudero
Session: ePoster Display
198P - Complications associated with prolonged GCSF with dose-dense EC chemotherapy for early breast cancer patients
Presenter: Taha Amir
Session: ePoster Display
200TiP - ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO
Presenter: Nadia Harbeck
Session: ePoster Display
201TiP - Evaluation of the feasibility of ultrasound-guided clipping of suspicious intramammary lesions in primary breast cancer patients receiving neoadjuvant therapy (Ultra3Detect)
Presenter: Efstathia Vlachou
Session: ePoster Display
143P - The impact of de-escalation of adjuvant systemic therapy on the outcome of women with early ER+/HER2+ breast cancer
Presenter: Valentina Jeric Horvat
Session: ePoster Display
144P - A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer
Presenter: Wolfgang Janni
Session: ePoster Display
204P - Predictive factors for relapse in triple-negative breast cancer (TNBC) patients without pathologic complete response (PCR)
Presenter: Marta Venturelli
Session: ePoster Display
205P - Immunomodulation in early triple-negative breast cancer (TNBC): Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in TNBC
Presenter: Martin Nunez Abad
Session: ePoster Display